Mobility, mood and site of care impact health related quality of life in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 3, 2014, Pages 274-279

  Nutt, J G ^a   Siderowf, A D ^b   Guttman, M ^c   Schmidt, P N ^d   Zamudio, J I ^d   Wu, S S ^e   Okun, M S ^d,e   Simuni, T ^f   Parashos, S A ^g   Dahodwala, N A ^b   Davis, T L ^h   Giladi, N ⁱ   Gurevich, T ⁱ   Hauser, R A ^j   Jankovic, J ^k   Lyons, K E ^l   Marsh, L ^m   Miyasaki, J M ⁿ   Morgan, J C ^o   Santiago, A J ^p,q   Tarsy, D ^r   Mari, Z ^s   Malaty, I A ^e   Nelson, E C ^t   more..

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d National Parkinson Foundation   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Struthers Parkinson Center   (United States)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l UNIVERSITY OF KANSAS   (United States)

^m DeBakey Veterans Affairs Medical Center   (United States)

ⁿ Toronto Western Hospital   (United States)

^o AUGUSTA UNIVERSITY   (United States)

^p Muhammad Ali Parkinson Center   (United States)

^q BARROW NEUROLOGICAL INSTITUTE   (United States)

^r BETH ISRAEL MEDICAL CENTER   (United States)

^s Johns Hopkins Medical Center   (United States)

^t DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

more..

Author keywords

Best practices; Health related quality of life; Parkinson's disease; Quality improvement

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; GOOD CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SOCIAL ASPECT; AFFECT; CLINICAL TRIAL; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PSYCHOLOGY; STANDARDS; VERY ELDERLY; WALKING DIFFICULTY;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; MOBILITY LIMITATION; OUTPATIENT CLINICS, HOSPITAL; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 84896398161     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.10.004     Document Type: Article

References (29)

1. Okun M.S., Siderowf A., Nutt J.G., O'Conner G.T., Bloem B.R., Olmstead E.M., et al. Piloting the NPF data-driven quality improvement initiative. Parkinsonism Relat Disord 2010 September, 16(8):517-521.
2. Martinez-Martin P., Kurtis M.M. Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord 2012 March, 5(2):105-117.
3. Soh S.E., Morris M.E., McGinley J.L. Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011 January, 17(1):1-9.
4. Schechter M.S., Gutierrez H.H. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr 2010 June, 22(3):296-301.
5. O'Connor G.T., Plume S.K., Olmstead E.M., Morton J.R., Maloney C.T., Nugent W.C., et al. Aregional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA 1996 March 20, 275(11):841-846.
6. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997 September, 26(5):353-357.
7. Martinez-Martin P., Jeukens-Visser M., Lyons K.E., Rodriguez-Blazquez C., Selai C., Siderowf A., et al. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord 2011 November, 26(13):2371-2380.
8. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999 January, 56(1):33-39.
9. Podsiadlo D., Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. JAm Geriatr Soc 1991 February, 39(2):142-148.
10. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. JAm Geriatr Soc 2005 April, 53(4):695-699.
11. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology 1967, 17:427-442.
12. Shulman L.M., Gruber-Baldini A.L., Anderson K.E., Vaughan C.G., Reich S.G., Fishman P.S., et al. The evolution of disability in Parkinson disease. Mov Disord 2008 April 30, 23(6):790-796.
13. Schrag A., Jahanshahi M., Quinn N. What contributes to quality of life in patients with Parkinson's disease?. JNeurol Neurosurg Psychiatry 2000 September, 69(3):308-312.
14. Muslimovic D., Post B., Speelman J.D., Schmand B., de Haan R.J. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008 June 3, 70(23):2241-2247.
15. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002 January, 17(1):60-67.
16. Hinnell C., Hurt C.S., Landau S., Brown R.G., Samuel M. Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease?. Mov Disord 2012 February, 27(2):236-241.
17. Peto V., Jenkinson C., Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 2001 July, 30(4):299-302.
18. Fitzpatrick R., Norquist J.M., Jenkinson C. Distribution-based criteria for change in health-related quality of life in Parkinson's disease. JClin Epidemiol 2004 January, 57(1):40-44.
19. Willis A.W., Schootman M., Evanoff B.A., Perlmutter J.S., Racette B.A. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology 2011 August 30, 77(9):851-857.
20. Ross J.S., Normand S.L., Wang Y., Ko D.T., Chen J., Drye E.E., et al. Hospital volume and 30-day mortality for three common medical conditions. NEngl J Med 2010 March 25, 362(12):1110-1118.
21. Knipe M.D., Wickremaratchi M.M., Wyatt-Haines E., Morris H.R., Ben-Shlomo Y. Quality of life in young- compared with late-onset Parkinson's disease. Mov Disord 2011 September, 26(11):2011-2018.
22. Winter Y., von C.S., Gasser J., Seppi K., Reese J.P., Pfeiffer K.P., et al. Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study. JNeurol 2010 April, 257(4):638-645.
23. Klepac N., Trkulja V., Relja M., Babic T. Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol 2008 February, 15(2):128-133.
24. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990, 40:1529-1534.
25. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009 August 15, 24(11):1641-1649.
26. Schrag A. Quality of life and depression in Parkinson's disease. JNeurol Sci 2006 October 25, 248(1-2):151-157.
27. Richard I.H., McDermott M.P., Kurlan R., Lyness J.M., Como P.G., Pearson N., et al. Arandomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 2012 April 17, 78(16):1229-1236.
28. Dobkin R.D., Menza M., Allen L.A., Gara M.A., Mark M.H., Tiu J., et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry 2011 October, 168(10):1066-1074.
29. Li F., Harmer P., Fitzgerald K., Eckstrom E., Stock R., Galver J., et al. Tai chi and postural stability in patients with Parkinson's disease. NEngl J Med 2012 February 9, 366(6):511-519.